Bio Green Med Solution (BGMS) Preferred Dividend Payments (2015 - 2026)
Bio Green Med Solution (BGMS) posted quarterly Preferred Dividend Payments of $20000.0 for Q1 2026, little changed quarter-over-quarter from $20000.0 in Q4 2025.
Powered by 
Analysis
Bio Green Med Solution (BGMS) Preferred Dividend Payments (2015 - 2026) Analysis & Trends
Bio Green Med Solution (BGMS) has reported Preferred Dividend Payments for 11 consecutive years, with $20000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Preferred Dividend Payments changed N/A year-over-year to $20000.0; the TTM figure through Mar 2026 stood at $81000.0 (changed N/A YoY), while the FY2025 annual figure was $61000.0, changed N/A from the prior year.
- Preferred Dividend Payments held at $20000.0 in Q1 2026 per BGMS's latest filing, from $20000.0 in the prior quarter.
- Across five years, Preferred Dividend Payments topped out at $50000.0 in Q1 2022 and bottomed at $20000.0 in Q2 2025.
- Historically, Preferred Dividend Payments has averaged $40083.3 across 4 years, with a median of $50000.0 in 2022.
- On a YoY basis, Preferred Dividend Payments climbed as much as 0.0% in 2022 and fell as far as 0.0% in 2022.
- Bio Green Med Solution's Preferred Dividend Payments stood at $50000.0 in 2022, then changed by 0.0% to $50000.0 in 2023, then slumped by 60.0% to $20000.0 in 2025, then changed by 0.0% to $20000.0 in 2026.
- Business Quant data shows BGMS's Preferred Dividend Payments at $20000.0 in Q1 2026, $20000.0 in Q4 2025, and $21000.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.56 Bn | 133.71 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 87.63 Bn | 79.64 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.65 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 60.24 Bn | 55.10 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.13 Bn | 44.13 Bn | - | - |
| 6 | BeOne Medicines | 40.46 Bn | 35.36 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.86 Bn | 32.56 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.00 Bn | 27.16 Bn | - | - |
| 9 | Insmed | 27.40 Bn | 26.24 Bn | 358.27 Mn | - |
| 10 | Bio Green Med Solution | 4.68 Mn | 886,595.10 | 79,000.00 | 20,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 20,000.00 |
| Mar 31, 2026 | 20,000.00 |
| Dec 31, 2025 | 20,000.00 |
| Sep 30, 2025 | 21,000.00 |
| Jun 30, 2025 | 20,000.00 |
| Dec 31, 2023 | 50,000.00 |
| Sep 30, 2023 | 50,000.00 |
| Jun 30, 2023 | 50,000.00 |
| Mar 31, 2023 | 50,000.00 |
| Dec 31, 2022 | 50,000.00 |
| Sep 30, 2022 | 50,000.00 |
| Jun 30, 2022 | 50,000.00 |
| Mar 31, 2022 | 50,000.00 |
| Dec 31, 2021 | 50,000.00 |
| Sep 30, 2021 | 50,000.00 |
| Jun 30, 2021 | 50,000.00 |
| Mar 31, 2021 | 50,000.00 |
| Dec 31, 2020 | 3.62 Mn |
| Sep 30, 2020 | 50,000.00 |
| Jun 30, 2020 | 50,000.00 |